Obsessive-compulsive disorder (OCD)

"He's an obsessive football fan."
"She's obsessive about shoes."
"He's a compulsive liar."

We use these phrases to describe people who think about something a lot or do something repeatedly, even when others can't see any reason for it. It isn't usually a problem and, in some lines of work, can even be helpful.

However, some people have distressing thoughts that come into their mind again and again, or experience urges to do the same thing again and again. This can come to dominate your life, stop you from enjoying things and even stop you from doing things you need to do.

So, if:

  • you get awful thoughts coming into your mind, even though you struggle to keep them out

or

  • you have to touch or count things, or repeat the same action like washing over and over again

you could have obsessive-compulsive disorder (OCD).

This leaflet is for anyone who has problems with obsessions or compulsions. We hope it will also be helpful for family and friends – and anyone else who wants to find out about OCD.

It describes what it’s like to have OCD, some of the help that is available, and how well it works, how you can help yourself and how to help someone else who is depressed. It also mentions some of the things we don't know about OCD. At the end of the leaflet, there is a list of other places to find more information, and references to the research on which this leaflet is based.

About our information

We publish information to help people understand more about mental health and mental illness, and the kind of care they are entitled to.

Our information isn't a substitute for personalised medical advice from a doctor or other qualified healthcare professional. We encourage you to speak to a medical professional if you need more information or support. Please read our disclaimer.

About OCD

Getting help

  1. Veale D, Freeston M, Krebs G, Heyman I, Salkovskis P. Risk assessment and management in obsessive-compulsive disorder. Adv Psychiatr Treat 2009; 15: 332-343.
  2. National Institute for Health and Care Excellence. Obsessive-compulsive disorder and body dysmorphic disorder: treatment. Clinical guideline 31. NICE; 2005.
  3. Veale D, Roberts A. Obsessive-compulsive disorder. BMJ 2014; 348: g2183.
  4. Pitman RK, Green RC, Jenike MA, Mesulam MM. Clinical comparison of Tourette’s disorder and obsessive-compulsive disorder. Am J Psychiatry 1987; 144: 1166-71.
  5. Kumar A, Trescher W, Byler D. Tourette syndrome and comorbid neuropsychiatric conditions. Curr Dev Disord Rep 2016; 3: 217-21.
  6. Cougle JR, Timpano KR, Fitch KE, Hawkins KA. Distress tolerance and obsessions: an integrative analysis. Depress Anxiety 2011; 28; 906-14.
  7. Morgado P, Freitas D, Bessa JM, Sousa N, Cergueira JJ. Perceived stress in obsessive-compulsive disorder is related with obsessive but not compulsive symptoms. Front Psychiatry 2013; 4: 21.
  8. Overbeek T, Schruers K, Vermetten E, Griez E. Comorbidity of obsessive-compulsive disorder and depression: prevalence, symptom severity, and treatment effect. J Clin Psychiatry 2002; 63: 1106-12.
  9. McKeon J, Roa B, Mann A. Life events and personality traits in obsessive-compulsive neurosis. Br J Psychiatry 1984; 144: 185-9.
  10. Murphy DL, Li Q, Engel S, Wichems C, Andrews A, Lesch K-P et al. Genetic perspectives on the serotonin transporter. Brain Res Bull 2001; 15: 487-94.
  11. Abramowitz JS, Deacon BJ, Whiteside SPH. Exposure Therapy for Anxiety: Principles and Practice. Guildford Press, 2011.
  12. Devane CL. Comparative safety and tolerability of selective serotonin reuptake inhibitors. Hum Psychopharmacol 1995; 10: S185-S193.
  13. Bloch MH, McGuire J, Landeros-Weisenberger A, Leckman JF, Pittenger C. Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder. Mol Psychiatry 2010; 15: 850-5.
  14. Haddad P. Do antidepressants have any potential to cause addiction? J Psychopharmacol 1999; 13: 300-7.
  15. Veale D. Cognitive behavioural-therapy for obsessive-compulsive disorder. Adv Psychiatr Treat 2007; 13: 438-46.
  16. Fesuner JD, Moody T, Lai TM, Sheen C, Khalsa S, Brown J et al. Brain connectivity and prediction of relapse after cognitive-behavioural therapy in obsessive-compulsive disorder. Front Psychiatry 2015; 6: 74.
  17. Lack CW. Obsessive-compulsive disorder: evidence-based treatments and future directions for research. World J Psychiatry 2012; 22: 86-90.
  18. Zohar J, Judge R. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators. Br J Psychiatry 1996; 169: 468-74.
  19. Katz RJ, De Veaugh-Geiss J, Landau P. Clomipramine in obsessive-compulsive disorder. Biol Psychiatry 1990; 28: 401-4.
  20. Simpson HB, Liebowitz MR, Foa EB, Kozak MJ, Schmidt AB, Rowan V et al. Post-treatment effects of exposure therapy and clomipramine in obsessive-compulsive disorder. Depress Anxiety 2004; 19: 225-33.
  21. Christensen H, Hadzi-Pavlovic D, Andrews G, Mattick R. Behavior therapy and tricyclic medication in the treatment of obsessive-compulsive disorder: a quantitative review. J Consult Clin Psychol 1987; 55: 701-11.
  22. Belotto-Silva C, Diniz JB, Malavazzi DM, Valério C, Fossaluza V, Borcato S et al. Group cognitive-behavioral therapy versus selective serotonin reuptake inhibitors for obsessive-compulsive disorder: a practical clinical trial. J Anxiety Disord 2012; 26: 25-31.
  23. Pallanti S, Grassi G, Sarrecchia ED, Cantisani A, Pellegrini M. Obsessive-compulsive disorder comorbidity: clinical assessment and therapeutic implications. Front Psychiatry 2011; 2: 70.
  24. Mancebo MC, Grant JE, Pinto A, Eisen JL, Rasmussen SA. Substance use disorders in an obsessive compulsive disorder clinical sample. J Anxiety Disord 2009; 23: 429-35.
  25. Kobak KA, Taylor LVH, Bystritsky A, Kohlenberg CJ, Griest JH, Tucker P et al. St John’s wort versus placebo in obsessive-compulsive disorder: results from a double-blind study. Int Clin Psychopharmacol 2005; 20: 299-304.
  26. Sarris J, Camfield D, Berk M. Complementary medicine, self-help, and lifestyle interventions for obsessive-compulsive disorder (OCD) and the OCD spectrum: a systematic review. J Affect Disord 2012; 138: 213-21.
  27. Zohar J, Westenberg HGM. Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand 2000; 403: 39-49.
  28. Tan KR, Brown M, Labouèbe G, Yvon C, Creton C, Fritschy J-M et al. Neural bases for addictive properties of benzodiazepines. Nature 2010; 463: 769-74.
  29. Hajak G, Müller WE, Wittchen HU, Pittrow D, Kirch W. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 2003; 98: 1371-8.
  30. Jenicke MA. Obsessive-compulsive disorder: efficacy of specific treatments as assessed by controlled trials. Psychopharmacol Bull 1993; 29: 487-99.

Credits

Expert review: Dr Paul Blenkiron

Series Editor: Dr Phil Timms 

Series Manager: Thomas Kennedy


Published: Oct 2019

© Royal College of Psychiatrists